Covid-19 in children: A brief overview after three months experience

Paediatr Respir Rev. 2020 Sep:35:9-14. doi: 10.1016/j.prrv.2020.05.006. Epub 2020 Jun 6.

Abstract

Severe Acute Respiratory Syndrome - Coronavirus - 2 (SARS-CoV-2) and its related Coronavirus Disease - 19 (COVID-19) has become a health emergency worldwide. The medical community has been concerned since the beginning of the outbreak about the potential impact of COVID-19 in children, especially in those with underlying chronic diseases. Fortunately, COVID-19 has been reported to be less severe in children than in adults. However, epidemiologic and clinical data are scarce. Children show unique features of SARS-CoV-2 involvement that may account for the low rate of infection and death in this age group. The purpose of this review is to summarize the most relevant evidence of COVID-19 in children highlighting similarities and differences with adults.

Keywords: COVID-19; Pediatrics; SARS.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Asymptomatic Infections / epidemiology
  • Betacoronavirus
  • COVID-19
  • Child
  • Child, Preschool
  • Comorbidity
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / physiopathology*
  • Coronavirus Infections / therapy
  • Cough / physiopathology*
  • Diarrhea / physiopathology
  • Fatigue / physiopathology
  • Female
  • Fever / physiopathology*
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Pandemics
  • Pharyngitis / physiopathology*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / physiopathology*
  • Pneumonia, Viral / therapy
  • Pregnancy
  • Pregnancy Complications, Infectious / physiopathology
  • SARS-CoV-2
  • Severity of Illness Index
  • Tachypnea / physiopathology*